Second Sight Medical, maker of the Argus II 'bionic eye,' files for an initial public offering worth nearly $32 million.
Second Sight Medical said today that it plans to raise $31.5 million in an initial public offering, likely next week.
Second Sight created the Argus II "bionic eye," the 1st retinal prosthesis approved for sale by the FDA.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1EmpXgp
Cap comentari:
Publica un comentari a l'entrada